ArticleCalcified tissue international1994
The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.
Article in Calcified tissue international, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 22 citations in OpenAlex.
- Assessing bone formation on hydrophilic and hydrophobic implant surfaces in a murine model treated with bisphosphonates.Clinical oral investigations · 2024Article
- Augmentation of IFN-γ by bone marrow derived immune cells in the presence of severe suppression of IFN-γ in gingivae induced by zoledronic acid and denosumab in Hu-BLT mice model of ONJ.Frontiers in endocrinology · 2023Article
- Effects of pamidronate administration on tooth eruption and mandibular growth in new born rats.Journal of Istanbul University Faculty of Dentistry · 2017Article
- Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws.Oncology letters · 2015Article
- The rate of osteoclastic destruction of calcified tissues is inversely proportional to mineral density.Calcified tissue international · 1995Article
- Volumes of chick and rat osteoclasts cultured on glass.Calcified tissue international · 1995Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Bisphosphonates (BP) are known to suppress osteoclastic resorption in vivo and in vitro, but doubt persists as to how, and the effect of BP on the resorptive capability of osteoclasts of known nuclear number is unknown. We aimed to find whether the addition of 3-amino-1-hydroxypropylidene-1,1- bisphosphonate (APD) changed the nuclear profile of an osteoclast population in vitro, and to measure the resorptive efficiency of individually characterized osteoclasts in the presence and absence of the BP. Prehatch chick bone cells were cultured for 24 hours on slices of dentine in medium with or without added APD at 10(-6) M or 10(-8) M, or in control medium on dentine presoaked with 10(-6) M APD for 48 hours. Total pit counts, and pit depths, areas and volumes for pits made by osteoclasts of known nuclear number, were found using confocal video-rate laser reflection microscopy and 3-D image analysis software. APD in the medium inhibited resorption and reduced the volume, area, and depth resorbed per nucleus per chick osteoclast. The nuclear number distribution did not shift significantly, suggesting that no preferential effect arose from the APD affecting one size of cell more than another. The large reduction found in pit numbers, depths, areas, and volumes in the APD dentine-pretreated group supports previous views that BP released during resorption act as metabolic inhibitors, altering protein synthesis by the cell. Larger cells made larger pits, but resorptive efficiency was similar for different cell sizes within the control or APD-treated groups.(ABSTRACT TRUNCATED AT 250 WORDS)
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.